Abvc Biopharma ABVC SEC Filings

NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Abvc Biopharma, Inc. (ABVC) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1424B4Prospectus0001213900-26-119790Nov 13, 2026 4:30 PM
2424B4Prospectus0001213900-26-119789Nov 13, 2026 4:30 PM
3424B4Prospectus0001213900-26-119791Nov 13, 2026 4:30 PM
4424B4Prospectus0001213900-26-119788Nov 13, 2026 4:30 PM
5S-3Prospectus0001213900-26-118178Nov 12, 2026 11:20 PM
610-QQuarterly & Annual Report0001213900-26-118078Nov 10, 2026 4:50 PM
7DOthers0001213900-26-118072Nov 10, 2026 4:45 PM
88-KCurrent Report0001213900-26-114729Nov 2, 2026 2:51 PM
9DEF 14AOthers0001213900-26-104509Sep 29, 2026 4:22 PM
10PRER14AOthers0001213900-26-099293Sep 11, 2026 8:30 PM
118-KCurrent Report0001213900-26-094152Aug 27, 2026 12:30 PM
12PRER14AOthers0001213900-26-093538Aug 25, 2026 8:30 PM
13424B4Prospectus0001213900-26-090779Aug 17, 2026 8:19 PM
14424B4Prospectus0001213900-26-090778Aug 17, 2026 8:18 PM
15424B4Prospectus0001213900-26-090777Aug 17, 2026 8:17 PM
16424B4Prospectus0001213900-26-090775Aug 17, 2026 8:16 PM
17PRER14AOthers0001213900-26-088445Aug 12, 2026 9:00 PM
1810-QQuarterly & Annual Report0001213900-26-088348Aug 12, 2026 8:06 PM
198-KCurrent Report0001213900-26-088165Aug 12, 2026 3:50 PM
208-KCurrent Report0001213900-26-084846Aug 4, 2026 1:12 AM
21PRE 14AOthers0001213900-26-082298Jul 28, 2026 8:31 PM
228-KCurrent Report0001213900-26-074949Jul 2, 2026 8:01 PM
2310-QQuarterly & Annual Report0001213900-26-058104May 18, 2026 11:22 AM
24NT 10-QQuarterly & Annual Report0001213900-26-057917May 15, 2026 9:00 PM
25POS AMOthers0001213900-26-035543Mar 27, 2026 8:30 PM
268-KCurrent Report0001213900-26-035499Mar 27, 2026 8:05 PM
27DEF 14AOthers0001213900-26-024122Mar 5, 2026 9:29 PM
2810-KQuarterly & Annual Report0001213900-26-023063Mar 3, 2026 9:20 PM
2910-QQuarterly & Annual Report0001213900-26-023062Mar 3, 2026 9:19 PM
308-KCurrent Report0001213900-26-023054Mar 3, 2026 9:14 PM
31PRE 14AOthers0001213900-26-012888Feb 5, 2026 10:29 PM
328-KCurrent Report0001213900-26-005165Jan 16, 2026 9:30 PM
33424B4Prospectus0001213900-25-110903Nov 14, 2025 9:29 PM
34424B4Prospectus0001213900-25-110902Nov 14, 2025 9:28 PM
35424B4Prospectus0001213900-25-110900Nov 14, 2025 9:28 PM
36424B4Prospectus0001213900-25-110898Nov 14, 2025 9:27 PM
378-KCurrent Report0001213900-25-104900Nov 3, 2025 12:30 PM
3810-QQuarterly & Annual Report0001213900-25-104811Nov 3, 2025 11:39 PM
398-KCurrent Report0001213900-25-103799Oct 30, 2025 12:31 PM
408-KCurrent Report0001213900-25-086952Sep 12, 2025 11:16 PM
41424B4Prospectus0001213900-25-077489Aug 15, 2025 8:24 PM
42424B4Prospectus0001213900-25-077487Aug 15, 2025 8:23 PM
43424B4Prospectus0001213900-25-077482Aug 15, 2025 8:21 PM
44424B4Prospectus0001213900-25-077476Aug 15, 2025 8:19 PM
45424B4Prospectus0001213900-25-077473Aug 15, 2025 8:18 PM
468-KCurrent Report0001213900-25-076018Aug 14, 2025 11:02 AM
47SCHEDULE 13GBeneficial Ownership Report0000929638-25-003007Aug 13, 2025 9:08 PM
4810-QQuarterly & Annual Report0001213900-25-075644Aug 13, 2025 8:02 PM
498-KCurrent Report0001213900-25-065728Jul 18, 2025 9:04 PM
50SCHEDULE 13DBeneficial Ownership Report0001213900-25-064283Jul 15, 2025 8:30 PM
...

Abvc Biopharma, Inc. SEC Filings API

Pull Abvc Biopharma, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ABVC&formtype=10-K,10-Q&api_key=YOUR_API_KEY